Melissa Smith, MD
Obstetrics & Gynecology · Slidell, LANPI 1114118932
Payments from drug & device makers
Across 231 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$737
- Mayne Pharma Commercial LLC$583
- Sumitomo Pharma America, Inc.$263
- Astellas Pharma US Inc$215
- Evofem Biosciences, Inc.$197
- Therapeuticsmd, Inc.$187
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,990100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $737 |
| Mayne Pharma Commercial LLC | 18 | $583 |
| Sumitomo Pharma America, Inc. | 16 | $263 |
| Astellas Pharma US Inc | 12 | $215 |
| Evofem Biosciences, Inc. | 13 | $197 |
| Therapeuticsmd, Inc. | 13 | $187 |
| Bayer | 10 | $143 |
| Organon | 8 | $143 |
| Pfizer | 7 | $134 |
| Hologic Sales And Service, LLC | 6 | $133 |
| Scynexis, Inc. | 7 | $125 |
| Avion Pharmaceuticals | 7 | $118 |
| Mylan Pharmaceuticals Inc. | 8 | $110 |
| Myovant Sciences Inc. | 6 | $94 |
| BD | 2 | $87 |
| Millicent US Inc | 6 | $85 |
| Merck | 4 | $67 |
| Pacira Pharmaceuticals Incorporated | 2 | $44 |
| Coopersurgical, Inc. | 3 | $39 |
| Exeltis, USA Inc. | 2 | $39 |
| Alfasigma USA, Inc. | 2 | $39 |
| Lupin Inc. | 3 | $37 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Exact Sciences | 2 | $35 |
| Vertex | 2 | $33 |
| Agile Therapeutics, Inc. | 2 | $32 |
| Boston Scientific | 2 | $32 |
| Asensus Surgical, Inc. | 2 | $31 |
| Vertical Pharmaceuticals, LLC | 2 | $27 |
| Johnson & Johnson | 1 | $22 |
| Meditrina | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Roche Diagnostics Corporation | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Inari Medical, Inc. | 1 | $14 |
| Shield Therapeutics Inc | 1 | $13 |
| Abbott | 1 | $12 |
| Renovia Inc | 1 | $11 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$4,001 in reported general payments places this provider in the 80th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 36 | $261 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Slidell
- Blake LandrySlidell$2M
- Alison RodriguezNew Orleans$10.5M
- Scott StriplinCovington$6.1M
- Samuel AlexanderMetairie$2.6M
- Clifton Nicholson-UhlMarrero$1.7M
- Brandon PerezMarrero$888K
- Earl PeeperNew Orleans$374K
- Veronica GillispieNew Orleans$237K
- Monty HeinenEunice$214K
- Rachel Bezdekla Place$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.